Take part in our inhibitor survey
We’re conducting a survey among people aged 16+ with a bleeding disorder who have an…Read more
Treatment Posts
Read more
Early Access for patients with inhibitors to Emicizumab
The MHRA has announced that Emicizumab (previously known as Ace910 and now marketed in the…Read more
Issue identified in BPL plasma products production
The Department of Health (DH) published a statement this morning regarding an issue identified during a…Read more
Bears4Rare: experts call on government to provide fair and fast access to treatments for rare disease patients
Rare conditions affect approximately 1 in 17 people in the UK.1 Although they are living…Read more
UK launches FibCLOT®▼ LFB’s human fibrinogen concentrate
LFB Biopharmaceuticals announced today the UK launch of FibCLOT, its human fibrinogen concentrate. This follows…Read more